Bovine Base Seerum

Lab Reagents

Bovine Serum Laboratories manufactures the bovine base seerum reagents distributed by Genprice. The Bovine Base Seerum reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Bovine Serum. Other Bovine products are available in stock. Specificity: Bovine Category: Base Group: Seerum

Seerum information

Erlotinib, Free Base

2048-1000
EUR 464.4

Sunitinib, Free base

2097-100
EUR 229.2

Sunitinib, Free base

2097-1000
EUR 601.2

Sunitinib, Free base

2097-25
EUR 138

Ruxolitinib (free base)

10-042 25 mg
EUR 418.2
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19).

Lapatinib, Free base

2138-100
EUR 464.4

Lapatinib, Free base

2138-25
EUR 229.2

Ruxolitinib, Free base

2139-100 Ask for price

Ruxolitinib, Free base

2139-25
EUR 639.6

Ruxolitinib, Free base

2139-5
EUR 248.4

Imatinib, Free base

2141-100
EUR 176.4

Imatinib, Free base

2141-1000
EUR 502.8

Linsitinib, Free base

2294-25
EUR 679.2

Linsitinib, Free base

2294-5
EUR 222

Tipifarnib, Free base

2296-1
EUR 170.4

Tipifarnib, Free base

2296-5
EUR 496.8

Rucaparib (free base)

A8893-10 10 mg
EUR 240
Description: Rucaparib, also named as AG-014699 or PF-01367338, is a poly (ADP ribose) polymerase (PARP) inhibitor. PARP is a DNA damage-activated nuclear enzyme that has a key signaling role in the base excision repair pathway.